References
- RowlandJHKentEEForsytheLPCancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other?Cancer2013119Suppl 112094210823695922
- American Cancer SocietyCancer Treatment and Survivorship Facts & Figures 2014–2015Atlanta, GAAmerican Cancer Society2014
- ZagadailovEFineMShieldsAPatient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payersAm Health Drug Benefits20136526427424991362
- BatlleJFArranzEEde Castro CarpeñoJOral chemotherapy: potential benefits and limitationsRev Oncol200466335340
- European Medicines AgencyEuropean Medicines Agency recommends approval of 44 medicines for human use and six medicines for veterinary use in first half 2013 Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/07/news_detail_001860jsp&mid=WC0b01ac058004d5c1Accessed June 2, 2015
- MahnerSHarterPFuxiusSPräferenz study – Patients’ individual choice for oral vs. intravenous Treosulfan in elderly patients with ovarian cancer: analysis of tolerability – for the North-Eastern German Society of Gynecological Oncology (NOGGO) study groupJ Cancer Res Clin Oncol2012138Suppl 182
- European Medicines AgencyEuropean public assessment reports2015 Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jspAccessed September 2, 2015
- LiuGFranssenEFitchMIWarnerEPatient preferences for oral versus intravenous palliative chemotherapyJ Clin Oncol19971511101158996131
- BornerMScheithauerWTwelvesCMarounJWilkeHAnswering patients’ needs: oral alternatives to intravenous therapyOncologist20016Suppl 4121611585969
- WeingartSNBrownEBachPBNCCN Task Force Report: Oral chemotherapyJ Natl Compr Cancer Netw20086Suppl 3S1S14
- PartridgeAHAvornJWangPSWinerEPAdherence to therapy with oral antineoplastic agentsJ Natl Cancer Inst200294965266111983753
- SchopfelJTowards a Prague Definition of Grey Literature Available from: http://greynet.org/images/GL12_S1P,_Sch_pfel.pdfAccessed May 6, 2015
- BraunVClarkeVUsing thematic analysis in psychologyQual Res Psychol20063277101
- BeusterienKGrinspanJKuchukIUse of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effectsOncologist201419212713424473225
- FallowfieldLStebbingJBraybrookeJLangridgeCJenkinsVThe preferences and experiences of different bisphosphonate treatments in women with breast cancerPsychooncology201120775576120878871
- GornasMSzczylikCOral treatment of metastatic breast cancer with capecitabine: what influences the decision-making process?Eur J Cancer Care (Engl)201019113113619686351
- IshitobiMShibuyaKKomoikeYKoyamaHInajiHPreferences for oral versus intravenous adjuvant chemotherapy among early breast cancer patientsPatient Prefer Adherence201371201120624293991
- PeetersLSibilleAAnrysBMaintenance therapy for advanced non-small-cell lung cancer: a pilot study on patients’ perceptionsJ Thorac Oncol2012781291129522659963
- SeamanSNelsonANobleSCancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative studyPatient Prefer Adherence2014845346124748774
- TeuffelOChengSEthierMCHealth-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patientsSupport Care Cancer201220112755276422350594
- CalhounEARolandPYConvenience is the main reason why ovarian cancer patients prefer oral regimen: ISPOR fifth annual international meeting, Arlington, VAValue Health200032134135
- SchottSSchneeweissAReinhardtJAcceptance of oral chemotherapy in breast cancer patients – a survey studyBMC Cancer20111112921486437
- BornerMMSchoffskiPde WitRPatient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancerEur J Cancer200238334935811818199
- PfeifferPMortensenJPBjerregaardBPatient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancerEur J Cancer200642162738274317011184
- DiBonaventuraMDCopherRBasurtoEFariaCLorenzoRPatient preferences and treatment adherence among women diagnosed with metastatic breast cancerAm Health Drug Benefits20147738639625525495
- CaroliFRaymondetPIzardIPlasJGallBDelgadoAOpinions of French patients with schizophrenia regarding injectable medicationPatient Prefer Adherence2011516517121573047
- CascianoRMalangoneERamachandranAGagliardinoJJA quantitative assessment of patient barriers to insulinInt J Clin Pract201165440841421401829
- LedermannJHarterPGourleyCOlaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trialLancet Oncol201415885286124882434